)
Visual
test
Bliss GVS Pharma
Bliss GVS Pharma (506197) investor relations material
Bliss GVS Pharma Q3 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 25/26 earnings summary10 Feb, 2026
Executive summary
Unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, were approved and released, with a limited review by auditors yielding unmodified conclusions.
An interim dividend of 0.50 paisa per equity share was declared for FY 2025-26, with a record date set for February 18, 2026.
Financial highlights
Standalone revenue from operations for the quarter ended December 31, 2025, was ₹16,468.07 lakh; consolidated revenue was ₹21,825.19 lakh.
Standalone net profit for the quarter was ₹1,860.71 lakh; consolidated net profit was ₹2,477.91 lakh.
For the nine months ended December 31, 2025, standalone net profit was ₹6,445.19 lakh; consolidated net profit was ₹9,772.90 lakh.
Basic EPS for the quarter was 1.76 (standalone) and 2.20 (consolidated); for nine months, 6.11 (standalone) and 8.86 (consolidated).
Outlook and guidance
The company continues to monitor regulatory changes, especially regarding the new Labour Codes, and will adjust accounting as needed.
Greenlife Bliss divestment's financial impact?
Why the significant rise in ESOP expense?
Rationale for new subsidiaries in Kenya and DRC?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Bliss GVS Pharma
- Strong Q1 FY26 growth in revenue and profit, with key subsidiary divestment completed.506197
Q1 25/2620 Nov 2025 - Strong revenue and profit growth, improved cash flow, and key management appointment in H1 FY26.506197Q2 25/2620 Nov 2025
- Revenue and net profit increased, with new leadership and regulatory fine payment noted.506197Q2 24/2520 Nov 2025
- Quarterly and nine-month profits rose, with ESOP share allotments and subsidiary impairments noted.506197Q3 24/2520 Nov 2025
- Revenue and net profit rose year-over-year, with key divestment and equity actions approved.506197Q4 24/2520 Nov 2025
- Q1 FY25 saw year-over-year growth in revenue and profit, with improved margins and ESOP activity.506197Q1 24/2520 Nov 2025
Next Bliss GVS Pharma earnings date
Q4 25/2630 Apr, 2026
Bliss GVS Pharma
Next Bliss GVS Pharma earnings date
Q4 25/2630 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage